Tetragon Partners GP LTD 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Tetragon Partners GP LTD disclosed 34 US equity positions worth $508.9m in its Q1 2026 13F filing. The largest position was PATH at 55.0% of the reported book, followed by KGEI and WBD.
What did Tetragon Partners GP LTD own in Q1 2026? Top 34 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | PATH UIPATH INC | Technology | 55.0% | $279.8m | 25,207,628 | – | |
| 2 | KGEI KOLIBRI GLOBAL ENERGY INC | 7.4% | $37.5m | 6,834,504 | – | ||
| 3 | WBD WARNER BROS DISCOVERY INC | Communication Services | 5.0% | $25.4m | 923,725 | – | |
| 4 | WK WORKIVA INC | Technology | 2.9% | $14.9m | 250,000 | – | |
| 5 | LYFT LYFT INC | Technology | 2.6% | $13.3m | 1,000,000 | – | |
| 6 | CXM SPRINKLR INC | Technology | 2.6% | $13.2m | 2,200,000 | – | |
| 7 | AUTL AUTOLUS THERAPEUTICS LTD | Healthcare | 2.6% | $13.1m | 9,500,000 | – | |
| 8 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.9% | $9.9m | 312,316 | – | |
| 9 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1.6% | $8.0m | 127,198 | – | |
| 10 | NKTR NEKTAR THERAPEUTICS | Healthcare | 1.5% | $7.4m | 103,037 | – | |
| 11 | ANNX ANNEXON INC | Healthcare | 1.4% | $7.2m | 1,292,455 | – | |
| 12 | PHVS PHARVARIS N V | Healthcare | 1.2% | $6.3m | 221,611 | – | |
| 13 | ALKS ALKERMES PLC | Healthcare | 1.1% | $5.7m | 159,791 | – | |
| 14 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.1% | $5.6m | 164,839 | – | |
| 15 | IMVT IMMUNOVANT INC | Healthcare | 1.1% | $5.4m | 218,507 | – | |
| 16 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 1.0% | $5.1m | 15,952 | – | |
| 17 | KRYS KRYSTAL BIOTECH INC | Healthcare | 1.0% | $5.1m | 19,668 | – | |
| 18 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.9% | $4.7m | 258,132 | – | |
| 19 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 0.9% | $4.4m | 317,877 | – | |
| 20 | MBX MBX BIOSCIENCES INC | Healthcare | 0.9% | $4.3m | 145,480 | – | |
| 21 | DFTX DEFINIUM THERAPEUTICS INC | Healthcare | 0.7% | $3.8m | 199,994 | – | |
| 22 | SLNOEUR SOLENO THERAPEUTICS INC | 0.7% | $3.4m | 102,125 | – | ||
| 23 | AXSM AXSOME THERAPEUTICS INC. | Healthcare | 0.7% | $3.4m | 20,059 | – | |
| 24 | HRMY HARMONY BIOSCIENCES HLDGS IN | Healthcare | 0.7% | $3.3m | 119,340 | – | |
| 25 | SLN SILENCE THERAPEUTICS PLC | 0.7% | $3.3m | 630,161 | – | ||
| 26 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 0.6% | $3.2m | 144,620 | – | |
| 27 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 0.6% | $3.1m | 41,764 | – | |
| 28 | MPLT MAPLIGHT THERAPEUTICS INC | 0.4% | $2.3m | 112,115 | – | ||
| 29 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.4% | $1.8m | 181,543 | – | |
| 30 | SNOW SNOWFLAKE INC | Technology | 0.3% | $1.5m | 10,000 | – | |
| 31 | AARD AARDVARK THERAPEUTICS INC | 0.2% | $1.2m | 316,621 | – | ||
| 32 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.2% | $1.2m | 37,588 | – | |
| 33 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 0.2% | $827.0k | 39,473 | – | |
| 34 | KPTI KARYOPHARM THERAPEUTICS INC | 0.1% | $295.1k | 52,984 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.